Medicalsystem Biotechnology Co., Ltd

XSEC:300439 Stock Report

Market Cap: CN¥4.2b

Medicalsystem Biotechnology Past Earnings Performance

Past criteria checks 4/6

Medicalsystem Biotechnology has been growing earnings at an average annual rate of 42.1%, while the Biotechs industry saw earnings growing at 7.6% annually. Revenues have been declining at an average rate of 9% per year. Medicalsystem Biotechnology's return on equity is 9%, and it has net margins of 13.8%.

Key information

42.1%

Earnings growth rate

41.6%

EPS growth rate

Biotechs Industry Growth11.3%
Revenue growth rate-9.0%
Return on equity9.0%
Net Margin13.8%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Medicalsystem Biotechnology makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

XSEC:300439 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 241,822251442146
30 Jun 241,858260432148
31 Mar 241,876264459149
31 Dec 231,886257445150
30 Sep 232,059225442165
30 Jun 232,175227486169
31 Mar 232,403200470175
01 Jan 232,489199516172
30 Sep 222,431210505167
30 Jun 222,421193508156
31 Mar 222,298174502154
31 Dec 212,252179497151
30 Sep 212,274173463148
30 Jun 212,304207464148
31 Mar 212,392209458142
31 Dec 202,302299447135
30 Sep 202,529-466485138
30 Jun 202,726-463539137
31 Mar 202,883-466544127
31 Dec 193,133-560572128
30 Sep 193,141248588131
30 Jun 193,203243548114
31 Mar 193,173242544113
31 Dec 183,135241544110
30 Sep 183,171264503100
30 Jun 182,948260446142
31 Mar 182,921257484116
31 Dec 172,58423046493
30 Sep 172,14519848359
30 Jun 171,7651894680
31 Mar 171,2011833950
31 Dec 161,0551773550
30 Sep 168631902790
30 Jun 167561802550
31 Mar 167081672410
31 Dec 156831612190
30 Sep 156501492250
30 Jun 156481492000
31 Mar 156321451780
31 Dec 145981381600
31 Dec 134321041180

Quality Earnings: 300439 has high quality earnings.

Growing Profit Margin: 300439's current net profit margins (13.8%) are higher than last year (10.9%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 300439's earnings have grown significantly by 42.1% per year over the past 5 years.

Accelerating Growth: 300439's earnings growth over the past year (11.5%) is below its 5-year average (42.1% per year).

Earnings vs Industry: 300439 earnings growth over the past year (11.5%) exceeded the Biotechs industry 1.3%.

Return on Equity

High ROE: 300439's Return on Equity (9%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/28 22:03
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Medicalsystem Biotechnology Co., Ltd is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Shuchang LiuChangjiang Securities Co. LTD.
Jiaxi XuIndustrial Securities Co. Ltd.
Yuan Yuan SunIndustrial Securities Co. Ltd.